Skip to main content
Premium Trial:

Request an Annual Quote

AB Sciex, Genedata, LECO to Collaborate on Metabolomics Software Development

NEW YORK (GenomeWeb News) – AB Sciex, Genedata, and LECO today announced a technology partnership to develop a collaborative software system to enable metabolomics researchers to comprehensively process and analyze experimental data across different GC/MS and LC/MS platforms.

The partnership brings together LECO's GC/MS expertise, AB Sciex's LC/MS expertise, and Genedata's experience in software development for drug discovery and life science research.

"The ability to bring data from different vendors and technologies onto a single platform, which can process and merge data for maximum biological inference, is where the industry needs to be to effectively evaluate the entire metabolome," Vladimir Tolstikov, scientist, Tailored Therapeutics at Eli Lilly, said in a statement commenting on the partnership.

The trio previously collaborated on the most recent version of Genedata's Expressionist MSX software, which was developed for metabolomics experiments performed with LECO and AB Sciex mass spec systems.

Financial and other terms of the agreement were not disclosed.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.